Related references
Note: Only part of the references are listed.Epi-miRNAs: Modern mediators of methylation status in human cancers
Maria-Alexandra Papadimitriou et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2023)
Effect of intrathecal NIS-lncRNA antisense oligonucleotides on neuropathic pain caused by nerve trauma, chemotherapy, or diabetes mellitus
Chun-Hsien Wen et al.
BRITISH JOURNAL OF ANAESTHESIA (2023)
miR-30a-5p promotes glomerular podocyte apoptosis via DNMT1-mediated hypermethylation under hyperhomocysteinemia
Ning Ding et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2022)
Molecular dynamics of estrogen-related receptors and their regulatory proteins: roles in transcriptional control for endocrine and metabolic signaling
Takashi Tanida
ANATOMICAL SCIENCE INTERNATIONAL (2022)
CircCDK1 knockdown reduces CDK1 expression by targeting miR-489-3p to suppress the development of breast cancer and strengthen the sensitivity of Tamoxifen
Di Liu et al.
ANTI-CANCER DRUGS (2022)
Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy
Behnoush Sohrabi et al.
CANCER GENE THERAPY (2022)
Analysis of the Estrogen Receptor-Associated LncRNA Landscape Identifies a Role for ERLC1 in Breast Cancer Progression
Hui Yuan et al.
CANCER RESEARCH (2022)
Transcriptional regulation of CYP19A1 expression in chickens: ESR1, ESR2 and NR5A2 form a functional network
Yan Guo et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2022)
Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights
Hamed Hosseinalizadeh et al.
MOLECULAR BIOLOGY REPORTS (2022)
Circular RNAs Modulate Cancer Hallmark and Molecular Pathways to Support Cancer Progression and Metastasis
Aliaksandr A. Yarmishyn et al.
CANCERS (2022)
Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
Deniz Mortazavi et al.
JOURNAL OF ONCOLOGY (2022)
Modulation of miRISC-Mediated Gene Silencing in Eukaryotes
Courtney F. Jungers et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study
Alfiah Amiruddin et al.
ANNALS OF MEDICINE AND SURGERY (2022)
LINC00094/miR-19a-3p/CYP19A1 axis affects the sensitivity of ER positive breast cancer cells to Letrozole through EMT pathway
Yuan Xiang et al.
Aging-US (2022)
Total circulating microRNA level as an independent prognostic marker for risk stratification in breast cancer
Aoife Ward Gahlawat et al.
BRITISH JOURNAL OF CANCER (2022)
Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics
Hyein Jo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Roles and clinical application of exosomal circRNAs in the diagnosis and treatment of malignant tumors
Dong Ye et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Prospect of exosomal circular RNAs in breast Cancer: presents and future
Elham Zokaei et al.
MOLECULAR BIOLOGY REPORTS (2022)
Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches
Hibah Shaath et al.
SEMINARS IN CANCER BIOLOGY (2022)
Circ_0060731 mediated miR-21-5p-PDCD4/ESR1 pathway to induce apoptosis of placental trophoblasts in intrahepatic cholestasis of pregnancy
Fan Feng et al.
TISSUE & CELL (2022)
Tumor-Derived circRNAs as Circulating Biomarkers for Breast Cancer
Yunhe Yu et al.
FRONTIERS IN PHARMACOLOGY (2022)
Circulating miRNAs in Breast Cancer Diagnosis and Prognosis
Barbara Cardinali et al.
CANCERS (2022)
Activity of Estrogen Receptor beta Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
Jharna Datta et al.
FRONTIERS IN ONCOLOGY (2022)
Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer
Tao Rui et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Long noncoding RNAs as promising biomarkers in cancer
Ozal Beylerli et al.
NON-CODING RNA RESEARCH (2022)
Circular RNA circMET contributes to tamoxifen resistance of breast cancer cells by targeting miR-204/AHR signaling
Junbiao Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Meta-analysis of diagnostic cell-free circulating microRNAs for breast cancer detection
Emir Sehovic et al.
BMC CANCER (2022)
Next RNA Therapeutics: The Mine of Non-Coding
Sabrina Garbo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer
Rosalba Torrisi et al.
SCIENTIFIC REPORTS (2022)
Potential utility of miRNAs for liquid biopsy in breast cancer
Xiangrong Liu et al.
FRONTIERS IN ONCOLOGY (2022)
LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside
Qin Hu et al.
CELL DEATH DISCOVERY (2022)
Apoptosis evasion via long non-coding RNAs in colorectal cancer
Muhammad Irfan et al.
CANCER CELL INTERNATIONAL (2022)
Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability
Oana Baldasici et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Knockdown circTRIM28 enhances tamoxifen sensitivity via the miR-409-3p/HMGA2 axis in breast cancer
Shiyong Yang et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2022)
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies
Rumeysa Ozyurt et al.
CANCERS (2022)
Exosomal MicroRNAs as Novel Cell-Free Therapeutics in Tissue Engineering and Regenerative Medicine
Eric Z. Zeng et al.
BIOMEDICINES (2022)
Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches
Hibah Shaath et al.
SEMINARS IN CANCER BIOLOGY (2022)
Plasma Exosomal hsa_circ_0015286 as a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer
Peiming Zheng et al.
PATHOLOGY & ONCOLOGY RESEARCH (2022)
HOTAIR Facilitates Endocrine Resistance in Breast Cancer Through ESR1/miR-130b-3p Axis: Comprehensive Analysis of mRNA-miRNA-lncRNA Network
Mingdi Zhang et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer
Nitish Kumar et al.
MOLECULAR DIVERSITY (2021)
miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers
Yulei Wei et al.
BREAST CANCER (2021)
Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p
Jianhui Liu et al.
CANCER CELL INTERNATIONAL (2021)
Interplay between DNA Methyltransferase 1 and microRNAs During Tu-morigenesis
Pooja Yadav et al.
CURRENT DRUG TARGETS (2021)
A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
Lea Clusan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer
Elizabeth M. Martin et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2021)
Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
Nina Petrovic et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2021)
RNA-binding proteins in human genetic disease
Fatima Gebauer et al.
NATURE REVIEWS GENETICS (2021)
Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/beta-Catenin Axis
Yanhong Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance
Olga E. Andreeva et al.
MOLECULES (2021)
Twist activates miR-22 to suppress estrogen receptor alpha in breast cancer
Farhad Vesuna et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
MicroRNA-100 inhibits breast cancer cell proliferation, invasion and migration by targeting FOXA1
Haihui Xie et al.
ONCOLOGY LETTERS (2021)
Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer
Hibah Shaath et al.
CANCERS (2021)
MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer
Neil Portman et al.
FRONTIERS IN ONCOLOGY (2021)
Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration
Hongmei Dong et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Advances of Exosomal miRNAs in Breast Cancer Progression and Diagnosis
Wenwen Chen et al.
DIAGNOSTICS (2021)
Exosomes provide unappreciated carrier effects that assist transfers of their miRNAs to targeted cells; I. They are 'The Elephant in the Room'
Philip W. Askenase
RNA BIOLOGY (2021)
Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer
Tatiana Kalinina et al.
GENES (2021)
Molecular Mechanisms of Endocrine Resistance in Estrogen-Positive Breast Cancer
Esmael Besufikad Belachew et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Dysregulation of miR-23b-5p promotes cell proliferation via targeting FOXM1 in hepatocellular carcinoma
Xinchen Yang et al.
CELL DEATH DISCOVERY (2021)
Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives
Li-Bo Tang et al.
BIOLOGY-BASEL (2021)
miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4
Yasuyuki Gen et al.
CANCER RESEARCH (2021)
Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network
Ying Liang et al.
NUCLEIC ACIDS RESEARCH (2021)
MicroRNA as an Important Target for Anticancer Drug Development
Zhiwen Fu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Circ_0040039 May Aggravate Intervertebral Disk Degeneration by Regulating the MiR-874-3p-ESR1 Pathway
Yongjin Li et al.
FRONTIERS IN GENETICS (2021)
From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells
Jessica Fernanda Barazetti et al.
CANCERS (2021)
ER-alpha 36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
Chunyan Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects
Cuicui Lu et al.
FRONTIERS IN ONCOLOGY (2021)
Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB
Arumugam Nagalingam et al.
NPJ BREAST CANCER (2021)
miR-221/222 sponge abrogates tamoxifen resistance in ER-positive breast cancer cells through restoring the expression of ERα
Yan Xiu Ouyang et al.
MOLECULAR BIOMEDICINE (2021)
Diagnostic Role of Long Non-Coding RNAs in Breast Cancer: a Systematic Review and Meta-Analysis
Xiaojiao Gao et al.
CLINICAL LABORATORY (2021)
Design and Functional Validation of a Mutant Variant o f the LncRNA HOTAIR to Counteract Snail Function in Epithelial-to-Mesenchymal Transition
Cecilia Battistelli et al.
CANCER RESEARCH (2021)
Circular RNA circTP63 enhances estrogen receptor-positive breast cancer progression and malignant behaviors through the miR-873-3p/FOXM1 axis
Yibin Deng et al.
ANTI-CANCER DRUGS (2021)
Regulation of gene expression by cis-acting long non-coding RNAs
Noa Gil et al.
NATURE REVIEWS GENETICS (2020)
Structure-Mediated RNA Decay by UPF1 and G3BP1
Joseph W. Fischer et al.
MOLECULAR CELL (2020)
Knockdown of PTEN decreases expression of estrogen receptor β and tamoxifen sensitivity of human breast cancer cells
Oliver Treeck et al.
STEROIDS (2020)
Identification of circRNA-miRNA networks for exploring an underlying prognosis strategy for breast cancer
Su-jin Yang et al.
EPIGENOMICS (2020)
Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients
Patricia M. M. Ozawa et al.
BIOMOLECULES (2020)
Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression
Wei Chen et al.
CANCER LETTERS (2020)
LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer
Tingting Ma et al.
CELLULAR SIGNALLING (2020)
FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cells
Hiroki Ide et al.
ENDOCRINE-RELATED CANCER (2020)
Uptake and tumor-suppressive pathways of exosome-associated GKN1 protein in gastric epithelial cells
Jung Hwan Yoon et al.
GASTRIC CANCER (2020)
Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen
Carmen W. H. Chan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Structure-Mediated Degradation of CircRNAs
Yingli Guo et al.
TRENDS IN CELL BIOLOGY (2020)
Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Breast Cancer Diagnosis
Guobin Zhong et al.
ONCOTARGETS AND THERAPY (2020)
The emerging role of the long non-coding RNA HOTAIR in breast cancer development and treatment
Hossein Mozdarani et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
MicroRNAs as Emerging Regulators of Signaling in the Tumor Microenvironment
Shahzad Nawaz Syed et al.
CANCERS (2020)
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer
Elena Alexandrova et al.
CELLS (2020)
LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis
Shi-Qin Liu et al.
BIOSCIENCE REPORTS (2020)
An HMGA2-p62-ERα axis regulates uterine leiomyomas proliferation
Binya Liu et al.
FASEB JOURNAL (2020)
Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p
Ke Hu et al.
MEDICAL SCIENCE MONITOR (2020)
Competing Endogenous RNAs, Non-Coding RNAs and Diseases: An Intertwined Story
Ugo Ala
CELLS (2020)
Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells
Xinchen Wang et al.
AGING-US (2020)
Long noncoding RNAs in cancer immunity: a new avenue in drug discovery
Anindya Dutta et al.
DRUG DISCOVERY TODAY (2020)
Beyond Back Splicing, a Still Poorly Explored World: Non-Canonical Circular RNAs
Annie Robic et al.
GENES (2020)
Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
Sarah A. Jeffreys et al.
CELLS (2020)
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
Qianfeng Shi et al.
NATURE COMMUNICATIONS (2020)
LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network
Yin Zhang et al.
THERANOSTICS (2020)
LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer
Yun Ma et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Regulation of microRNA function in animals
Luca F. R. Gebert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Estrogen-independent Myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ERαY537S and ERαD538G mutations
Liqun Yu et al.
CANCER LETTERS (2019)
miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancer
Behzad Mansoori et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Circular RNA expression in exosomes derived from breast cancer cells and patients
Jinyan Wang et al.
EPIGENOMICS (2019)
Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER plus Breast Cancer
Julie A. Vendrell et al.
FRONTIERS IN PHARMACOLOGY (2019)
Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients
Shicong Tang et al.
JOURNAL OF BIOSCIENCES (2019)
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
Yuting Sang et al.
MOLECULAR THERAPY (2019)
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy
Gines Luengo-Gil et al.
CELLULAR ONCOLOGY (2019)
Exosomal circRNAs: biogenesis, effect and application in human diseases
Yangxia Wang et al.
MOLECULAR CANCER (2019)
Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum
Yu-yang Feng et al.
PLOS ONE (2019)
Dicer1 facilitates liver regeneration in a manner dependent on the inhibitory effect of miR-21 on Pten and Rhob expression
Tao Lv et al.
LIFE SCIENCES (2019)
ESR1-Stabilizing Long Noncoding RNA TMPO-AS1 Promotes Hormone-Refractory Breast Cancer Progression
Yuichi Mitobe et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
Pathways to Endocrine Therapy Resistance in Breast Cancer
Md Moquitul Haque et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Obesity impacts the regulation of miR-10b and its targets in primary breast tumors
Ari Meerson et al.
BMC CANCER (2019)
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
Malgorzata Szostakowska et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer
Irida Kastrati et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis
Liyuan Fan et al.
MOLECULAR CANCER (2019)
The biochemical basis of microRNA targeting efficacy
Sean E. McGeary et al.
SCIENCE (2019)
Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease
Juliane C. R. Fernandes et al.
NON-CODING RNA (2019)
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
Alba Rodriguez-Martinez et al.
BREAST CANCER RESEARCH (2019)
Long Non-Coding RNA LINC00511 Mediates the Effects of ESR1 on Proliferation and Invasion of Ovarian Cancer Through miR-424-5p and miR-370-5p
Kang Wang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes
Shengli Li et al.
NUCLEIC ACIDS RESEARCH (2018)
High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival
Zhanwei Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer
Weijie Zhang et al.
CANCER RESEARCH (2018)
Functional Classification and Experimental Dissection of Long Noncoding RNAs
Florian Kopp et al.
CELL (2018)
Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers
Carolyn M. Klinge
ENDOCRINE-RELATED CANCER (2018)
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
Nicola Amodio et al.
LEUKEMIA (2018)
Estrogen and progesterone signalling in the normal breast and its implications for cancer development
Heidi N. Hilton et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer
Mithil Soni et al.
MOLECULAR CANCER RESEARCH (2018)
Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas
S. Begum et al.
ONCOGENE (2018)
Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer
K. Uhr et al.
SCIENTIFIC REPORTS (2018)
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Erin W. Howard et al.
BIOLOGICAL PROCEDURES ONLINE (2018)
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes
Martine Croset et al.
CANCER RESEARCH (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process
Hongli Gao et al.
ONCOTARGETS AND THERAPY (2018)
DSCAM-AS1 regulates the G1/S cell cycle transition and is an independent prognostic factor of poor survival in luminal breast cancer patients treated with endocrine therapy
Wei Sun et al.
CANCER MEDICINE (2018)
CCAAT enhancer binding protein β promotes tumor growth and inhibits apoptosis in prostate cancer by methylating estrogen receptor β
D. Li et al.
NEOPLASMA (2018)
miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22
Jun Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1
Dan Wang et al.
ACTA PHARMACOLOGICA SINICA (2018)
A Review of Physical Activity and Circulating miRNA Expression: Implications in Cancer Risk and Progression
Suzanne Dufresne et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells
Pratima Basak et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
MicroRNA-335-5p and-3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance
Elizabeth C. Martin et al.
FEBS LETTERS (2017)
Identification of miRNAs as biomarkers for acquired endocrine resistance in breast cancer
Penn Muluhngwi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer
Wan-xin Peng et al.
MOLECULAR CANCER (2017)
IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells
Ali Vaziri-Gohar et al.
MOLECULAR CANCER RESEARCH (2017)
Cell-to-cell communication: microRNAs as hormones
Recep Bayraktar et al.
MOLECULAR ONCOLOGY (2017)
Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1
Kotb Abdelmohsen et al.
RNA BIOLOGY (2017)
Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function
Monika Piwecka et al.
SCIENCE (2017)
ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer
Jianbo Zhang et al.
CELL DEATH & DISEASE (2017)
Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis
Bin Li et al.
ONCOTARGET (2017)
How do lncRNAs regulate transcription?
Yicheng Long et al.
SCIENCE ADVANCES (2017)
Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587
Javier Figueroa et al.
CANCER RESEARCH (2017)
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss
Gayatri Arun et al.
GENES & DEVELOPMENT (2016)
Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming
Caroline H. Diep et al.
MOLECULAR CANCER RESEARCH (2016)
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
X. Xue et al.
ONCOGENE (2016)
RISC assembly: Coordination between small RNAs and Argonaute proteins
Hotaka Kobayashi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells
Xinfeng Yu et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy
James N. Ingle et al.
CANCER RESEARCH (2016)
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors
Marina Bacci et al.
CANCER RESEARCH (2016)
Over-expression of miR-451a can enhance the sensitivity of breast cancer cells to tamoxifen by regulating 14-3-3ζ, estrogen receptor α, and autophagy
Zhen-Ru Liu et al.
LIFE SCIENCES (2016)
Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2
William W. Du et al.
NUCLEIC ACIDS RESEARCH (2016)
An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells
Jeanette Baran-Gale et al.
RNA (2016)
MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha
Li Han et al.
TUMOR BIOLOGY (2016)
Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop
Xiunan Li et al.
TUMOR BIOLOGY (2016)
Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression
Jiang Zhu et al.
CELL DEATH & DISEASE (2016)
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression
Yashar S. Niknafs et al.
NATURE COMMUNICATIONS (2016)
Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer
Nai-si Huang et al.
ONCOTARGET (2016)
A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth
Yogin Patel et al.
ONCOTARGET (2016)
miRNAs involved in LY6K and estrogen receptor a contribute to tamoxifen-susceptibility in breast cancer
Ye Sol Kim et al.
ONCOTARGET (2016)
Long Non-coding RNAs in the Cytoplasm
Farooq Rashid et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2016)
Considering Exosomal miR-21 as a Biomarker for Cancer
Jian Shi
JOURNAL OF CLINICAL MEDICINE (2016)
MiR 221/222 as New Players in Tamoxifen Resistance
Nafiseh Sadat Alamolhodaei et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer
Zhike Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer
Fu-Gui Ye et al.
CANCER RESEARCH (2015)
A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance
Douglas M. Anderson et al.
CELL (2015)
The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients
Nina G. Egeland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
What have we learned about GPER function in physiology and disease from knockout mice?
Eric R. Prossnitz et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells
Zhike Chen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
Yao-Yin Chang et al.
MOLECULAR CANCER (2015)
Structure of a Biologically Active Estrogen Receptor-Coactivator Complex on DNA
Ping Yi et al.
MOLECULAR CELL (2015)
Human Argonaute 2 Has Diverse Reaction Pathways on Target RNAs
Myung Hyun Jo et al.
MOLECULAR CELL (2015)
Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells
Rammohan Devulapally et al.
MOLECULAR PHARMACEUTICS (2015)
Long Non-Coding RNA Regulation of Reproduction and Development
David H. Taylor et al.
MOLECULAR REPRODUCTION AND DEVELOPMENT (2015)
NON-CODING RNA Towards a molecular understanding of microRNA-mediated gene silencing
Stefanie Jonas et al.
NATURE REVIEWS GENETICS (2015)
Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer
Sanaa Eissa et al.
TRANSLATIONAL RESEARCH (2015)
The biological functions of miRNAs: lessons from in vivo studies
Joana A. Vidigal et al.
TRENDS IN CELL BIOLOGY (2015)
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
Pascale A. Cohen et al.
ONCOTARGET (2015)
MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ
Mingrong Lu et al.
SCIENTIFIC REPORTS (2015)
Rolling Circle Translation of Circular RNA in Living Human Cells
Naoko Abe et al.
SCIENTIFIC REPORTS (2015)
ENDOCRINE THERAPY IN BREAST CANCER: THE NEOADJUVANT, ADJUVANT, AND METASTATIC APPROACH
Raquel E. Reinbolt et al.
SEMINARS IN ONCOLOGY NURSING (2015)
Loss of Estrogen-Regulated microRNA Expression Increases HER2 Signaling and Is Prognostic of Poor Outcome in Luminal Breast Cancer
Shannon T. Bailey et al.
CANCER RESEARCH (2015)
MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer
Paul Vilquin et al.
BREAST CANCER RESEARCH (2015)
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha
Seth Frietze et al.
BMC GENOMICS (2014)
Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
Yifang Wei et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer
Manoj M. Pillai et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis
Ling-Min Kong et al.
CANCER RESEARCH (2014)
Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary
Sarah A. Best et al.
DEVELOPMENT (2014)
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
Ramesh Singh et al.
MOLECULAR CANCER (2014)
A functional interplay between ZNF217 and Estrogen Receptor alpha exists in luminal breast cancers
Nhan T. Nguyen et al.
MOLECULAR ONCOLOGY (2014)
Detecting and characterizing circular RNAs
William R. Jeck et al.
NATURE BIOTECHNOLOGY (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
Elisabetta Crippa et al.
PLOS ONE (2014)
The HER2-Encoded miR-4728-3p Regulates ESR1 through a Non-Canonical Internal Seed Interaction
Inga Newie et al.
PLOS ONE (2014)
Tyrosine Phosphatase Shp2 Mediates the Estrogen Biological Action in Breast Cancer via Interaction with the Estrogen Extranuclear Receptor
Jun Li et al.
PLOS ONE (2014)
Human DDX6 effects miRNA-mediated gene silencing via direct binding to CNOT1
Christopher Rouya et al.
RNA (2014)
Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
Corinna Eichelser et al.
ONCOTARGET (2014)
Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers
S. J. Elliman et al.
ONCOGENESIS (2014)
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
Anna Bergamaschi et al.
BREAST CANCER RESEARCH (2014)
The c-Myc-Regulated MicroRNA-17∼92 (miR-17∼92) and miR-106a∼363 Clusters Target hCYP19A1 and hGCM1 To Inhibit Human Trophoblast Differentiation
Premlata Kumar et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
SIRT1-Mediated FoxO1 Deacetylation Is Essential for Multidrug Resistance-Associated Protein 2 Expression in Tamoxifen-Resistant Breast Cancer Cells
Hoo-Kyun Choi et al.
MOLECULAR PHARMACEUTICS (2013)
Natural RNA circles function as efficient microRNA sponges
Thomas B. Hansen et al.
NATURE (2013)
Circular RNAs are a large class of animal RNAs with regulatory potency
Sebastian Memczak et al.
NATURE (2013)
Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer
T. Hulf et al.
ONCOGENE (2013)
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
A. Ward et al.
ONCOGENE (2013)
microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models
Bahauddeen M. Alrfaei et al.
PLOS ONE (2013)
miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer
Yue-Jun He et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells
Deborah A. Sanders et al.
GENOME BIOLOGY (2013)
Global Characterization of the SRC-1 Transcriptome Identifies ADAM22 as an ER-Independent Mediator of Endocrine-Resistant Breast Cancer
Damian McCartan et al.
CANCER RESEARCH (2012)
Landscape of transcription in human cells
Sarah Djebali et al.
NATURE (2012)
Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
A. Bergamaschi et al.
ONCOGENE (2012)
The Orphan Nuclear Receptor LRH-1 and ERα Activate GREB1 Expression to Induce Breast Cancer Cell Proliferation
Ashwini L. Chand et al.
PLOS ONE (2012)
MiR-137 Targets Estrogen-Related Receptor Alpha and Impairs the Proliferative and Migratory Capacity of Breast Cancer Cells
Yuanyin Zhao et al.
PLOS ONE (2012)
Aryl Hydrocarbon Receptor Modulation of Estrogen Receptor α-Mediated Gene Regulation by a Multimeric Chromatin Complex Involving the Two Receptors and the Coregulator RIP140
Zeynep Madak-Erdogan et al.
TOXICOLOGICAL SCIENCES (2012)
miRNAs and estrogen action
Carolyn M. Klinge
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status
Zhenduo Lu et al.
ONCOLOGY LETTERS (2012)
Posttranscriptional Upregulation by MicroRNAs
Shobha Vasudevan
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer
Yingchun Zhao et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance
Todd W. Miller et al.
CLINICAL CANCER RESEARCH (2011)
Estrogen Induces c-myc Gene Expression via an Upstream Enhancer Activated by the Estrogen Receptor and the AP-1 Transcription Factor
Chunyu Wang et al.
MOLECULAR ENDOCRINOLOGY (2011)
let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast Cancer
Yingchun Zhao et al.
MOLECULAR MEDICINE (2011)
Tumor-specific Expression of MicroRNA-26a Suppresses Human Hepatocellular Carcinoma Growth via Cyclin-dependent and -independent Pathways
Lizao Chen et al.
MOLECULAR THERAPY (2011)
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
X. Rao et al.
ONCOGENE (2011)
Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer
Hakeemah Al-Nakhle et al.
CANCER RESEARCH (2010)
Oncogenic HER2δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
Diana M. Cittelly et al.
CARCINOGENESIS (2010)
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells
R. Spizzo et al.
CELL DEATH AND DIFFERENTIATION (2010)
MicroRNA: Biogenesis, Function and Role in Cancer
Leigh-Ann MacFarlane et al.
CURRENT GENOMICS (2010)
MiR-205 silences MED1 in hypoxic primary human trophoblasts
Jean-Francois Mouillet et al.
FASEB JOURNAL (2010)
An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples
Jianhua Xiong et al.
FEBS JOURNAL (2010)
The protein encoded by the functional steroid receptor RNA activator is a new modulator of ER alpha transcriptional activity
Shilpa Chooniedass-Kothari et al.
FEBS LETTERS (2010)
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
Diana M. Cittelly et al.
MOLECULAR CANCER (2010)
p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication
Ian G. Cannell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer
Dawn R. Cochrane et al.
Hormones & Cancer (2010)
MicroRNA-18a Prevents Estrogen Receptor-α Expression, Promoting Proliferation of Hepatocellular Carcinoma Cells
Wan-Hsin Liu et al.
GASTROENTEROLOGY (2009)
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
Liang Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA
Deo Prakash Pandey et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The Role of miR-206 in the Epidermal Growth Factor (EGF) Induced Repression of Estrogen Receptor-α (ERα) Signaling and a Luminal Phenotype in MCF-7 Breast Cancer Cells
Brian D. Adams et al.
MOLECULAR ENDOCRINOLOGY (2009)
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
S-K Leivonen et al.
ONCOGENE (2009)
The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response
Leandro Castellano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
ERRγ Mediates Tamoxifen Resistance in Novel Models of Invasive Lobular Breast Cancer
Rebecca B. Riggins et al.
CANCER RESEARCH (2008)
miR-206 expression is down-regulated in estrogen receptor α-positive human breast cancer
Naoto Kondo et al.
CANCER RESEARCH (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest
Fang Sun et al.
FEBS LETTERS (2008)
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines
Brian D. Adams et al.
MOLECULAR ENDOCRINOLOGY (2007)
Enhanced NFκB and AP-I transcriptional activity associated with antiestrogen resistant breast cancer
Yamei Zhou et al.
BMC CANCER (2007)
c-Myc overexpression and endocrine resistance in breast cancer
Catriona M. McNeil et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA
Anwar Hossain et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
MRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes
Isabelle Behm-Ansmant et al.
GENES & DEVELOPMENT (2006)
Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter
Fabio Stossi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Estrogen receptors as therapeutic targets in breast cancer
Eric A. Ariazi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway
SQ Guo et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
SRA coactivation of estrogen receptor-α is phosphorylation-independent, and enhances 4-hydroxytamoxifen agonist activity
KM Coleman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The aryl hydrocarbon receptor mediates degradation of estrogen receptor α through activation of proteasomes
M Wormke et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Opposing action of estrogen receptors α and β on cyclin D1 gene expression
MM Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
17β-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence
B Perillo et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
